| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424940660 | Acid proteinases (3.4.23) (e.g., pepsin, renin, chymosin, etc.) | 8 |
| 20090136478 | Methods for using enzymes to disintegrate cancerous tumors in vivo - Methods to disintegrate cancerous tissue in vivo, using proteolytic enzyme compound for the digestion of the cancer cells. These methods exploit the fact that there is a significant difference in the strength and layout of the protein fraction between the normal and the cancer cells. | 05-28-2009 |
| 20140140980 | TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS - Provided herein are compositions, foods comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof for modulating gluten intolerance and related conditions, such as celiac disease. | 05-22-2014 |
| 20140186330 | TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS - Provided herein are compositions, foods comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof for modulating gluten intolerance and related conditions, such as celiac disease. Further provided herein are pharmaceutical compositions comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof to treat bacterial infections of the gastrointestinal tract, such as | 07-03-2014 |
| 20140369996 | Chymosin for the Prevention and Treatment of Gastrointestinal Disorders - The present invention is directed to medical or dietary treatments comprising administration of a zymogen such as chymosin or other rennins. Embodiments of the invention are directed to treating infant colic, heartburn, gastro-esophageal reflux (GER), gastro-esophageal reflux disease (GERD), irritable bowel syndrome, and recurrent abdominal pain. The invention is also directed to improving absorption of calcium from milk for osteoporosis patients. Further the present invention may have a very positive effect on life quality for groups with different chronic digestion problems such as ulcerous colitis, multiple sclerosis, migraines, weight disorders and diabetes. Infants may be given several drops of a composition containing chymosin prior to every feeding, regardless of whether they are bottle or breast-fed. The composition containing chymosin can also be incorporated into a food product such as drinking milk or baby formula. The rennin helps infants break down milk proteins so that the milk can be transformed into cheese pulp in the stomach, mimicking the process occurring in the stomachs of normal infants. | 12-18-2014 |
| 20150017151 | PHARMACEUTICAL FORMULATIONS OF XANTHINE OR XANTHINE DERIVATIVES, AND THEIR USE - The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration. | 01-15-2015 |
| 20150290301 | TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS - Provided herein are compositions, foods comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof for modulating gluten intolerance and related conditions, such as celiac disease. Further provided herein are pharmaceutical compositions comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof to treat bacterial infections of the gastrointestinal tract, such as | 10-15-2015 |
| 20160022785 | COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM - The invention described herein relates to methods and compositions for treatment of gluten intolerance and related conditions (e.g., celiac disease and gluten sensitivity), or inhibition of inflammation and/or immune response in the intestine due to antigenic food peptides, by administration of a pharmaceutical composition comprising one or more | 01-28-2016 |
| 20160186160 | ASPARTIC PROTEASES - The invention relates to aspartic proteases, and particularly to aspartic proteases for plants. Disclosed are modified plant aspartic proteases, and methods for their manufacture, and uses thereof. Particularly contemplated are the uses of aspartic proteases in inducing skin desquamation. | 06-30-2016 |
